Optimizing Intervention Effects in Children and Adolescents

July 4, 2025 updated by: Ningbo No. 1 Hospital

Optimizing Intervention Effects in Children and Adolescents in Ningbo City

Childhood obesity is a significant public health concern worldwide. In China, childhood obesity has dramatically increased as the economy has grown quickly over the past decades. Effective strategies to reduce childhood obesity prevalence may help to prevent related chronic diseases in the whole population in the long term.

This study aimed (1)to assess the effectiveness of the intervention compared with the usual practice in preventing childhood overweight and obesity; (2) to determine the sustainability of the intervention in preventing overweight and obesity; and (3) to evaluate the process and health economics of the intervention.

The project will be carried out in six primary schools in Ningbo City, Zhejiang Province , those schools are randomly divided into two groups: the intervention group and the usual practice group. The participants of the study were students in the third grade of primary school, and the intervention will last for one academic year. This intervention programme will target the influencing factors of childhood obesity at both individual (student-focused activities) and environmental levels (a supportive family and school environment), with the intent to influence the knowledge, attitude and behaviours of school children.

Study Overview

Status

Active, not recruiting

Conditions

Study Type

Interventional

Enrollment (Actual)

1627

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ningbo, China
        • Ningbo First Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 10 years (Child)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Parents agree and support their children's weight loss, and students and parents have informed consent;
  • Students in third grade aged 8 to 10 years old.

Exclusion Criteria:

  • medical history of heart disease, hypertension, diabetes, tuberculosis, asthma, hepatitis or nephritis;
  • obesity caused by endocrine diseases or side effects of drugs;
  • abnormal physical development like dwarfism or gigantism;
  • physical deformity such as severe scoliosis, pectus carinatum, limp, obvious O-leg or X-leg;
  • inability to participate in school sport activities;
  • a loss in weight by vomiting or taking drugs during the past 3 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
The students of this group will receive multi-faceted intervention activities toward weight management.

This intervention programme will target the influencing factors of childhood obesity to influence the knowledge, attitude and behaviours of school children. Students in the intervention group will receive the following interventions:

  • Develop and implement school policies related to weight loss
  • Distribute health education materials on diet and exercise to students
  • Carry out student health education courses
No Intervention: Usual practice group
The students of this group will receive regular health education.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in body mass index (BMI)
Time Frame: 9months , 24 months and 36 months
  • weight and height will be combined to report BMI in kg/m^2
  • caculated by terminal value minus baseline value
9months , 24 months and 36 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in blood glucose
Time Frame: 9 months
caculated by terminal value minus baseline value
9 months
change in blood lipids
Time Frame: 9 months
  • include TC, TG, LDL-C, HDL-C
  • caculated by terminal value minus baseline value
9 months
change in fasting insulin
Time Frame: 9 months
caculated by terminal value minus baseline value
9 months
change in body fat percentage
Time Frame: 9 months
caculated by terminal value minus baseline value
9 months
change in BMI z- score
Time Frame: 9months , 24 months and 36 months
  • measures of relative weight adjusted for child age and sex
  • caculated by terminal value minus baseline value
9months , 24 months and 36 months
change in waist circumference
Time Frame: 9 months, 24 months and 36 months
caculated by terminal value minus baseline value
9 months, 24 months and 36 months
change in weight
Time Frame: 9months, 24 months and 36 months
caculated by terminal value minus baseline value
9months, 24 months and 36 months
change in cardiorespiratory endurance test
Time Frame: 9 months, 24 months and 36 months
caculated by terminal value minus baseline value
9 months, 24 months and 36 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2022

Primary Completion (Actual)

June 25, 2023

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

July 28, 2022

First Submitted That Met QC Criteria

July 28, 2022

First Posted (Actual)

August 1, 2022

Study Record Updates

Last Update Posted (Actual)

July 9, 2025

Last Update Submitted That Met QC Criteria

July 4, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2021-R168

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Childhood Obesity

Clinical Trials on Multi-faceted health promotion programme

Subscribe